BIOA: BioAge Labs, Inc. Common Stock Company Profile & Statistics

BioAge Labs, Inc. Common Stock Profile

About

BioAge Labs Inc. is a clinical-stage biopharmaceutical company. It involved in developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging. BioAge Labs Inc. is based in RICHMOND, Calif.

Info & Links

CEO

Kristen Fortney

Headquarters

1445A SOUTH 50TH STREET
RICHMOND, CA 94804, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

BioAge Labs, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

443.53M

Enterprise Value

232.08M

Enterprise Value/EBITDA(ttm)

-2.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

1.62

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

Profit Margin(ttm)

-691.75%

Return on Equity(ttm)

-25.08%

Return on Invested Capital(ttm)

-25.19%

Return on Assets(ttm)

-22.81%

Income Statement

Revenue(ttm)

5.92M

Revenue Per Share(ttm)

0.17

Gross Profit(ttm)

5.92M

EBITDA(ttm)³

-89.53M

Net Income Available to Common(ttm)

-75.79M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.74

52-Week Change

202.32%

S&P 500 52-Week Change

15.37%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

35.86M

Dividend Yield

0.00%

Float⁴

28.39M

% Held by Insiders

20.82%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

285.78M

Total Cash Per Share(mrq)

7.97

Total Debt(mrq)

4.13M

Total Debt/Equity(mrq)

1.49%

Current Ratio(mrq)

11.87%

Quick Ratio(mrq)

11.87%

Book Value Per Share(mrq)

7.74

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.49

Free Cash Flow(ytd)

-53.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BIOA

BioAge Labs, Inc. Common Stock